Buscar resultados de ensayos clínicos
Paraparesis - 85 Studies Found
Estado | Estudiar |
Enrolling by invitation |
Nombre del estudio: Evaluation of the MP Diagnostics HTLV Blot 2.4 Condición:
|
Completed |
Nombre del estudio: Physiologic Studies of Spasticity Condición:
Fecha: 2001-04-17 |
Completed |
Nombre del estudio: Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis Condición:
|
Completed |
Nombre del estudio: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis Condición: Tropical Spastic Paraparesis Fecha: 2002-05-01 |
Not yet recruiting |
Nombre del estudio: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Condición:
Fecha: 2015-11-16 Intervenciones: Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Completed |
Nombre del estudio: Effects of Therapeutic Music Combined With Loaded Sit-to-Stand Resistance Exercise for Children With Spastic Diplegia Condición:
Fecha: 2010-08-09 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condición: HTLV-I-Associated Myelopathy Fecha: 2011-04-25 Intervenciones: Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
Nombre del estudio: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Condición: HTLV-I Fecha: 2006-06-19 |
Recruiting |
Nombre del estudio: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Condición: HTLV-1 Fecha: 2006-07-12 Intervenciones: Drug: Hu MiK-Beta-1 |
Enrolling by invitation |
Nombre del estudio: Urological Physical Therapy in HTLV-1 With Urinary Symptoms Condición:
Fecha: 2012-07-25 Intervenciones: Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |